Hydreight Technologies Inc. Announces Strategic Investment in Insu Therapeutics to Advance Needle-Free Peptide Delivery Technology

AI Briefing

• – Hydreight Technologies Inc. announces investment in Insu Therapeutics to advance needle-free peptide delivery technology.
• – The investment aims to accelerate the development of Insu Therapeutics' peptide delivery platform.
• – The collaboration will focus on bringing innovative treatments to patients with chronic diseases.